France is a world leader for research and manufacturing of veterinary medicines and reagents, in Europe, with more than 5500 employees, and the largest therapeutic pharmacopoeia (2800 drugs approuved). Four French companies (Merial Virbac, Ceva, Vetoquinol) are in the first 10 laboratories in the world.
The overall attractiveness of France for animal health issues is due to the density of the industrial network (5 major platforms), the recognized scientific and technical expertise in biotechnology and in some therapeutic areas and the ability of French manufacturers to lead or take part to international R&D project.
France is the largest European market with € 835 million in sales and global export reached € 1.4 billion in export which € 400 million for the only European Union (45% in 5 years).
The veterinary medicines industry spends only 10 to 12% of revenue in R&D, to ensure 4% to 6% growth through innovation per year.